Stock News

Lederer & Associates Investment Counsel Increases Holding in Celgene (CELG); Abner Herrman & Brock Holds Stake in Intel (INTC)

Intel Corporation (NASDAQ:INTC) Logo

Abner Herrman & Brock Llc increased its stake in Intel Corp (INTC) by 421.12% based on its latest 2017Q4 regulatory filing with the SEC. Abner Herrman & Brock Llc bought 83,520 shares as the company’s stock rose 9.61% while stock markets declined. The institutional investor held 103,353 shares of the semiconductors company at the end of 2017Q4, valued at $4.77 million, up from 19,833 at the end of the previous reported quarter. Abner Herrman & Brock Llc who had been investing in Intel Corp for a number of months, seems to be bullish on the $255.14B market cap company. The stock decreased 0.83% or $0.46 during the last trading session, reaching $54.75. About 17.80 million shares traded. Intel Corporation (NASDAQ:INTC) has risen 44.65% since May 25, 2017 and is uptrending. It has outperformed by 33.10% the S&P500.

Lederer & Associates Investment Counsel increased its stake in Celgene (CELG) by 22.39% based on its latest 2017Q4 regulatory filing with the SEC. Lederer & Associates Investment Counsel bought 3,246 shares as the company’s stock declined 19.30% with the market. The institutional investor held 17,745 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.85 million, up from 14,499 at the end of the previous reported quarter. Lederer & Associates Investment Counsel who had been investing in Celgene for a number of months, seems to be bullish on the $57.77 billion market cap company. The stock increased 2.42% or $1.88 during the last trading session, reaching $79.54. About 7.88 million shares traded or 5.03% up from the average. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 25, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Investors sentiment decreased to 1.02 in Q4 2017. Its down 0.01, from 1.03 in 2017Q3. It is negative, as 60 investors sold INTC shares while 703 reduced holdings. 177 funds opened positions while 601 raised stakes. 3.06 billion shares or 0.43% more from 3.05 billion shares in 2017Q3 were reported. Silvercrest Asset Gru Ltd Company accumulated 1.29M shares or 0.55% of the stock. 14,452 were reported by Mckinley Carter Wealth Services. American Asset Management Inc reported 8,266 shares or 0.23% of all its holdings. Fagan Associate reported 39,423 shares. Vigilant Cap Mgmt Limited Liability Corp reported 5,554 shares. Moneta Inv Advsrs Limited Com holds 17,440 shares. Foundry Partners Ltd Liability Corp holds 0.02% in Intel Corporation (NASDAQ:INTC) or 9,721 shares. Tortoise Mngmt Ltd Liability Company owns 669 shares. Newman Dignan Sheerar Inc invested in 2.03% or 88,066 shares. Stock Yards Bancshares has invested 0.4% in Intel Corporation (NASDAQ:INTC). Paragon Capital Mgmt reported 17,221 shares. Garrison Corp invested 0.29% in Intel Corporation (NASDAQ:INTC). Jacobs Levy Equity Mngmt Incorporated holds 0.26% or 323,059 shares in its portfolio. Northeast Mngmt reported 65,018 shares. Ny State Teachers Retirement owns 8.11M shares for 0.89% of their portfolio.

Among 55 analysts covering Intel Corporation (NASDAQ:INTC), 36 have Buy rating, 3 Sell and 16 Hold. Therefore 65% are positive. Intel Corporation had 264 analyst reports since August 7, 2015 according to SRatingsIntel. Nomura maintained the stock with “Buy” rating in Monday, September 19 report. The firm has “Buy” rating by Mizuho given on Thursday, October 26. As per Friday, January 15, the company rating was maintained by Stifel Nicolaus. The rating was maintained by Goldman Sachs with “Neutral” on Wednesday, April 20. The rating was maintained by Oppenheimer with “Hold” on Wednesday, June 14. Mizuho maintained the shares of INTC in report on Monday, September 19 with “Buy” rating. The firm earned “Buy” rating on Monday, September 19 by Argus Research. RBC Capital Markets maintained the shares of INTC in report on Monday, April 2 with “Hold” rating. The firm has “Buy” rating given on Monday, August 24 by Canaccord Genuity. As per Friday, November 20, the company rating was maintained by Topeka Capital Markets.

Abner Herrman & Brock Llc, which manages about $1.13 billion and $594.27M US Long portfolio, decreased its stake in Schlumberger Ltd (NYSE:SLB) by 11,615 shares to 87,098 shares, valued at $5.87 million in 2017Q4, according to the filing. It also reduced its holding in General Electric Co (NYSE:GE) by 36,400 shares in the quarter, leaving it with 21,149 shares, and cut its stake in Boeing Co (NYSE:BA).

Since January 22, 2018, it had 0 insider buys, and 21 sales for $11.14 million activity. Krzanich Brian M sold $427,757 worth of stock. 17,946 shares valued at $880,540 were sold by RENDUCHINTALA VENKATA S M on Wednesday, January 31. Another trade for 686 shares valued at $31,943 was sold by McBride Kevin Thomas. HUNDT REED E had sold 20,000 shares worth $1.07M. BRYANT ANDY D sold $1.89 million worth of stock or 35,693 shares. YOFFIE DAVID B had sold 25,000 shares worth $1.33M.

More notable recent Intel Corporation (NASDAQ:INTC) news were published by: Seekingalpha.com which released: “Lam Research: Riding The Wave Of Semiconductor Luau” on May 24, 2018, also Seekingalpha.com with their article: “Big self-driving car deal for Mobileye” published on May 17, 2018, Bizjournals.com published: “Intel beats its first quarter earnings, raises full-year guidance” on April 26, 2018. More interesting news about Intel Corporation (NASDAQ:INTC) were released by: Bizjournals.com and their article: “Intel reassigns marketing chief” published on May 14, 2018 as well as Fool.com‘s news article titled: “These 2 Intel Executives Need to Be Replaced” with publication date: May 23, 2018.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It is negative, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Interocean Limited Liability Company accumulated 0.04% or 3,123 shares. First Merchants Corporation reported 3,810 shares. Baker Avenue Asset Management Lp, California-based fund reported 16,875 shares. 2,250 are owned by Grandfield & Dodd Ltd Limited Liability Company. Boston Family Office Limited Liability owns 1.56% invested in Celgene Corporation (NASDAQ:CELG) for 136,085 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 342,640 shares. Kcm Investment Lc stated it has 0.02% in Celgene Corporation (NASDAQ:CELG). Qci Asset Mgmt Inc Ny invested in 42 shares or 0% of the stock. Aviance Lc has invested 0.61% of its portfolio in Celgene Corporation (NASDAQ:CELG). Iguana Health Mngmt Lc accumulated 5.1% or 75,000 shares. Ccm Invest Advisers Lc, South Carolina-based fund reported 10,465 shares. Dana Advsr holds 0.21% or 46,850 shares. Alps Advsrs accumulated 0% or 5,177 shares. Retail Bank Of Hawaii holds 15,811 shares or 0.13% of its portfolio. Johnson Fincl Gru invested in 0.15% or 11,477 shares.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 148 analyst reports since July 21, 2015 according to SRatingsIntel. Bernstein downgraded Celgene Corporation (NASDAQ:CELG) on Wednesday, December 27 to “Market Perform” rating. The rating was maintained by Jefferies on Sunday, October 15 with “Buy”. The firm earned “Buy” rating on Friday, November 6 by UBS. Jefferies maintained the stock with “Buy” rating in Friday, June 23 report. Canaccord Genuity maintained Celgene Corporation (NASDAQ:CELG) rating on Tuesday, June 6. Canaccord Genuity has “Buy” rating and $15600 target. The rating was maintained by Cowen & Co with “Outperform” on Wednesday, August 12. The stock of Celgene Corporation (NASDAQ:CELG) has “Neutral” rating given on Friday, June 30 by BTIG Research. The stock has “Buy” rating by RBC Capital Markets on Wednesday, October 4. The stock of Celgene Corporation (NASDAQ:CELG) earned “Hold” rating by Piper Jaffray on Thursday, January 25. The stock of Celgene Corporation (NASDAQ:CELG) has “Neutral” rating given on Friday, October 20 by Robert W. Baird.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Nasdaq.com which released: “Warren Buffett’s Mentor Was Right About the Crazy Market — and 2 Biotech Stocks Prove It” on May 23, 2018, also Seekingalpha.com with their article: “My 2 Cents On The Ozanimod Saga” published on May 15, 2018, Seekingalpha.com published: “Celgene: Still (Looks) Appealing” on May 21, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Finance.Yahoo.com and their article: “5 Top Stock Trades for Tuesday Morning” published on May 22, 2018 as well as Seekingalpha.com‘s news article titled: “Generic Revlimid Could Sink Celgene” with publication date: May 16, 2018.

Since February 8, 2018, it had 2 insider purchases, and 3 selling transactions for $3.48 million activity. Another trade for 18,500 shares valued at $1.77 million was sold by KAPLAN GILLA. MARIO ERNEST had sold 13,370 shares worth $1.26M on Friday, February 23. On Monday, March 12 LOUGHLIN JAMES J sold $851,093 worth of Celgene Corporation (NASDAQ:CELG) or 9,250 shares.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *